Biological markers of prognosis in transitional cell carcinoma of the bladder: current concepts.
Aprikian
A G
AG
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Sarkis
A S
AS
Reuter
V E
VE
Cordon-Cardo
C
C
Sheinfeld
J
J
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D001789:Blood Group Antigens; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis / Q000453:epidemiology*; D016147:Genes, Tumor Suppressor; D006801:Humans; D011379:Prognosis; D016160:Retinoblastoma Protein; D016159:Tumor Suppressor Protein p53; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000453:epidemiology*
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D001789:Blood Group Antigens; D016160:Retinoblastoma Protein; D016159:Tumor Suppressor Protein p53